{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:36:11Z","timestamp":1777926971323,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.104","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T10:38:37Z","timestamp":1284719917000},"page":"7414-7419","source":"Crossref","is-referenced-by-count":58,"title":["Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: Role of CD4+ and CD8+ T cells"],"prefix":"10.1016","volume":"28","author":[{"given":"Alberto Yairh","family":"Limon-Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Cervera-Cetina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan L.","family":"Tzec-Arjona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Ek-Macias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilma","family":"S\u00e1nchez-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Ramirez-Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Vladimir","family":"Cruz-Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole R.","family":"VanWynsberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dumonteil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.104_bib0005","doi-asserted-by":"crossref","first-page":"b1283","DOI":"10.1136\/bmj.b1283","article-title":"Eliminating Chagas disease: challenges and a roadmap","volume":"338","author":"Reithinger","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1590\/S0036-36341999000400010","article-title":"Update on Chagas\u2019 disease in Mexico","volume":"41","author":"Dumonteil","year":"1999","journal-title":"Salud Publica Mex"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.104_bib0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1590\/S0074-02762002000500002","article-title":"The impact of Chagas disease control in Latin America: a review","volume":"97","author":"Dias","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006","journal-title":"Trends Parasitol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.08.104_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.08.104_bib0030","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1371\/journal.pmed.0040332","article-title":"The challenges of Chagas Disease\u2014grim outlook or glimmer of hope","volume":"4","author":"Tarleton","year":"2007","journal-title":"PLoS Med"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2010.08.104_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0020-7519(01)00158-8","article-title":"Parasite persistence in the aetiology of Chagas disease","volume":"31","author":"Tarleton","year":"2001","journal-title":"Int J Parasitol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.08.104_bib0040","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/IAI.00423-07","article-title":"Modulation of autoimmunity by treatment of an infectious disease","volume":"75","author":"Hyland","year":"2007","journal-title":"Infect Immun"},{"issue":"March (9)","key":"10.1016\/j.vaccine.2010.08.104_bib0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0050","doi-asserted-by":"crossref","first-page":"90520","DOI":"10.1155\/2007\/90520","article-title":"DNA vaccines against protozoan parasites: opportunities and challenges","volume":"2007","author":"Dumonteil","year":"2007","journal-title":"J Biomed Biotechnol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.08.104_bib0235","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era","volume":"9","author":"Dumonteil","year":"2009","journal-title":"Infect Genet Evol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.08.104_bib0060","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00142-08","article-title":"Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas\u2019 disease","volume":"15","author":"Silveira","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"June (8)","key":"10.1016\/j.vaccine.2010.08.104_bib0065","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice","volume":"15","author":"Bhatia","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2010.08.104_bib0070","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/S0264-410X(03)00121-X","article-title":"Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection","volume":"21","author":"Fralish","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2010.08.104_bib0075","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/IAI.66.11.5073-5081.1998","article-title":"Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection","volume":"66","author":"Wizel","year":"1998","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.08.104_bib0080","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/IAI.74.4.2477-2481.2006","article-title":"Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice","volume":"74","author":"Tzelepis","year":"2006","journal-title":"Infect Immun"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.08.104_bib0085","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1128\/IAI.73.11.7356-7365.2005","article-title":"Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection","volume":"73","author":"Miyahira","year":"2005","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.08.104_bib0090","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","article-title":"CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2","volume":"73","author":"Araujo","year":"2005","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.08.104_bib0095","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1371\/journal.ppat.0020077","article-title":"CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes","volume":"2","author":"Martin","year":"2006","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.104_bib0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","article-title":"Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice","volume":"72","author":"Dumonteil","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative efficacy of DNA vaccines encoding various Trypanosoma cruzi antigens","volume":"50","author":"Sanchez-Burgos","year":"2007","journal-title":"FEMS Microbiol Med Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.104_bib0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.imlet.2005.11.015","article-title":"Control of Trypanosoma cruzi infection and changes in T cell populations induced by a therapeutic DNA vaccine in mice","volume":"103","author":"Zapata-Estrella","year":"2006","journal-title":"Immunol Lett"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.08.104_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4269\/ajtmh.1993.48.161","article-title":"Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection","volume":"48","author":"Sun","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.104_bib0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0035-9203(88)90271-4","article-title":"Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+)","volume":"82","author":"Ben Younes-Chennoufi","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.08.104_bib0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/IAI.60.3.1024-1030.1992","article-title":"CD8+ cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase of Trypanosoma cruzi infection in rats","volume":"60","author":"Sato","year":"1992","journal-title":"Infect Immun"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2010.08.104_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2143\/AC.60.1.2005046","article-title":"Acute Chagas\u2019 disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens","volume":"60","author":"Fuenmayor","year":"2005","journal-title":"Acta Cardiol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.104_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01614765","article-title":"Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process","volume":"423","author":"Higuchi Mde","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.08.104_bib0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","article-title":"Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+ CD8+ lymphocytes","volume":"48","author":"Reis","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.104_bib0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1590\/S0074-02762000000400005","article-title":"Mexican Trypanosoma cruzi stocks: analysis of minicircle kDNA homologies by cross-hybridization","volume":"95","author":"Bosseno","year":"2000","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0264-410X(99)00151-6","article-title":"Enhancement of DNA vaccine potency using conventional aluminum adjuvants","volume":"18","author":"Ulmer","year":"1999","journal-title":"Vaccine"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2010.08.104_bib0155","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1016\/j.vaccine.2005.05.037","article-title":"Aluminium phosphate potentiates DNA vaccines against Leishmania mexicana","volume":"23","author":"Rosado-Vallado","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.104_bib0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00428-001-0542-4","article-title":"Immunohistochemical studies in acute and chronic canine chagasic cardiomyopathy","volume":"441","author":"Caliari","year":"2002","journal-title":"Virchows Arch"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2010.08.104_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0074-02762009000900037","article-title":"Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice","volume":"104","author":"Rodrigues","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"May (8)","key":"10.1016\/j.vaccine.2010.08.104_bib0170","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00087-07","article-title":"Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection","volume":"14","author":"Duthie","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"September (41)","key":"10.1016\/j.vaccine.2010.08.104_bib0175","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1016\/j.vaccine.2009.07.013","article-title":"Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection","volume":"27","author":"Haolla","year":"2009","journal-title":"Vaccine"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2010.08.104_bib0180","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1016\/j.vaccine.2007.05.022","article-title":"Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells","volume":"25","author":"de Alencar","year":"2007","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.08.104_bib0185","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/IAI.01459-08","article-title":"Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination","volume":"77","author":"de Alencar","year":"2009","journal-title":"Infect Immun"},{"issue":"October","key":"10.1016\/j.vaccine.2010.08.104_bib0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","article-title":"Generation, specificity, and function of CD8 T cells in Trypanosoma cruzi infection","volume":"201","author":"Martin","year":"2004","journal-title":"Immunol Rev"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2010.08.104_bib0195","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"Hoft","year":"2007","journal-title":"J Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.08.104_bib0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.coi.2009.07.006","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"21","author":"Padilla","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.08.104_bib0205","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.180.3.1737","article-title":"Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance","volume":"180","author":"Tzelepis","year":"2008","journal-title":"J Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.08.104_bib0210","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/IAI.61.12.5129-5133.1993","article-title":"Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei","volume":"61","author":"Rottenberg","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.104_bib0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/356338a0","article-title":"Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection","volume":"356","author":"Tarleton","year":"1992","journal-title":"Nature"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.08.104_bib0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/IAI.01245-06","article-title":"Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells","volume":"75","author":"Padilla","year":"2007","journal-title":"Infect Immun"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.08.104_bib0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbrc.2009.12.166","article-title":"Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi","volume":"392","author":"Chou","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.08.104_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.micinf.2007.11.010","article-title":"Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein","volume":"10","author":"Chou","year":"2008","journal-title":"Microbes Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10012946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10012946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T21:19:09Z","timestamp":1591910349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10012946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":46,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10012946"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}